423 related articles for article (PubMed ID: 32784608)
21. Ankylosing spondylitis and mesenchymal stromal/stem cell therapy: a new therapeutic approach.
Abdolmohammadi K; Pakdel FD; Aghaei H; Assadiasl S; Fatahi Y; Rouzbahani NH; Rezaiemanesh A; Soleimani M; Tayebi L; Nicknam MH
Biomed Pharmacother; 2019 Jan; 109():1196-1205. PubMed ID: 30551369
[TBL] [Abstract][Full Text] [Related]
22. Assessment of mesenchymal stem/stromal cell-based therapy in K/BxN serum transfer-induced arthritis.
Lopez-Santalla M; Conde C; Rodriguez-Trillo A; Garin MI
Front Immunol; 2022; 13():943293. PubMed ID: 36300108
[TBL] [Abstract][Full Text] [Related]
23. Rheumatoid arthritis: the old issue, the new therapeutic approach.
Babaahmadi M; Tayebi B; Gholipour NM; Kamardi MT; Heidari S; Baharvand H; Eslaminejad MB; Hajizadeh-Saffar E; Hassani SN
Stem Cell Res Ther; 2023 Sep; 14(1):268. PubMed ID: 37741991
[TBL] [Abstract][Full Text] [Related]
24. Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis.
Shin TH; Kim HS; Kang TW; Lee BC; Lee HY; Kim YJ; Shin JH; Seo Y; Won Choi S; Lee S; Shin K; Seo KW; Kang KS
Cell Death Dis; 2016 Dec; 7(12):e2524. PubMed ID: 28005072
[TBL] [Abstract][Full Text] [Related]
25. Umbilical Cord Mesenchymal Stem Cell Therapy for Regenerative Treatment of Rheumatoid Arthritis: Opportunities and Challenges.
Lv X; Wang L; Zou X; Huang S
Drug Des Devel Ther; 2021; 15():3927-3936. PubMed ID: 34584402
[TBL] [Abstract][Full Text] [Related]
26. Meta-analysis of preclinical studies of mesenchymal stromal cells to treat rheumatoid arthritis.
Liu L; Wong CW; Han M; Farhoodi HP; Liu G; Liu Y; Liao W; Zhao W
EBioMedicine; 2019 Sep; 47():563-577. PubMed ID: 31501076
[TBL] [Abstract][Full Text] [Related]
27. Yields of mesenchymal stromal cells from synovial fluid reflect those from synovium in patients with rheumatoid arthritis.
Kohno Y; Mizuno M; Endo K; Ozeki N; Katano H; Matsumoto M; Kaneko H; Takazawa Y; Koga H; Sekiya I
Tissue Cell; 2022 Apr; 75():101727. PubMed ID: 34998163
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal stromal cell therapy for patients with rheumatoid arthritis.
Harna B; Kalra P; Arya S; Jeyaraman N; Nallakumarasamy A; Jeyaraman M; Rajendran RL; Oh EJ; Khanna M; Rajendran UM; Chung HY; Ahn BC; Gangadaran P
Exp Cell Res; 2023 Feb; 423(1):113468. PubMed ID: 36621669
[TBL] [Abstract][Full Text] [Related]
29. Immunomodulatory effect of human umbilical cord mesenchymal stem cells on T lymphocytes in rheumatoid arthritis.
Ma D; Xu K; Zhang G; Liu Y; Gao J; Tian M; Wei C; Li J; Zhang L
Int Immunopharmacol; 2019 Sep; 74():105687. PubMed ID: 31295689
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cells, autoimmunity and rheumatoid arthritis.
El-Jawhari JJ; El-Sherbiny YM; Jones EA; McGonagle D
QJM; 2014 Jul; 107(7):505-14. PubMed ID: 24518000
[TBL] [Abstract][Full Text] [Related]
31. Targeting Mesenchymal Stromal Cells/Pericytes (MSCs) With Pulsed Electromagnetic Field (PEMF) Has the Potential to Treat Rheumatoid Arthritis.
Ross CL; Ang DC; Almeida-Porada G
Front Immunol; 2019; 10():266. PubMed ID: 30886614
[TBL] [Abstract][Full Text] [Related]
32. Development of a Functional Biomarker for Use in Cell-Based Therapy Studies in Seropositive Rheumatoid Arthritis.
Shalev-Malul G; Soler DC; Ting AE; Lehman NA; Barnboym E; McCormick TS; Anthony DD; Lazarus HM; Caplan AI; Breitman M; Singer NG
Stem Cells Transl Med; 2016 May; 5(5):628-31. PubMed ID: 27025689
[TBL] [Abstract][Full Text] [Related]
33. The Outcome of Stem Cell-Based Therapies on the Immune Responses in Rheumatoid Arthritis.
Roudsari PP; Alavi-Moghadam S; Rezaei-Tavirani M; Goodarzi P; Tayanloo-Beik A; Sayahpour FA; Larijani B; Arjmand B
Adv Exp Med Biol; 2021; 1326():159-186. PubMed ID: 32926346
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow mesenchymal stem cells in rheumatoid arthritis, spondyloarthritis, and ankylosing spondylitis: problems rather than solutions?
Berthelot JM; Le Goff B; Maugars Y
Arthritis Res Ther; 2019 Nov; 21(1):239. PubMed ID: 31722720
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal Stem Cell Therapy for Autoimmune Disease: Risks and Rewards.
Munir H; McGettrick HM
Stem Cells Dev; 2015 Sep; 24(18):2091-100. PubMed ID: 26068030
[TBL] [Abstract][Full Text] [Related]
36. Intravenous Infusion of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Rheumatoid Arthritis: A Phase Ia Clinical Trial.
Park EH; Lim HS; Lee S; Roh K; Seo KW; Kang KS; Shin K
Stem Cells Transl Med; 2018 Sep; 7(9):636-642. PubMed ID: 30112846
[TBL] [Abstract][Full Text] [Related]
37. Cellular and Molecular Targets of Extracellular Vesicles from Mesenchymal Stem/Stromal Cells in Rheumatoid Arthritis.
Alcaraz MJ; Guillén MI
Stem Cells Transl Med; 2022 Dec; 11(12):1177-1185. PubMed ID: 36318277
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal stromal cells in rheumatoid arthritis: biological properties and clinical applications.
Kastrinaki MC; Papadaki HA
Curr Stem Cell Res Ther; 2009 Jan; 4(1):61-9. PubMed ID: 19149631
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I/II Study.
Wang L; Huang S; Li S; Li M; Shi J; Bai W; Wang Q; Zheng L; Liu Y
Drug Des Devel Ther; 2019; 13():4331-4340. PubMed ID: 31908418
[TBL] [Abstract][Full Text] [Related]
40. Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial.
Shadmanfar S; Labibzadeh N; Emadedin M; Jaroughi N; Azimian V; Mardpour S; Kakroodi FA; Bolurieh T; Hosseini SE; Chehrazi M; Niknejadi M; Baharvand H; Gharibdoost F; Aghdami N
Cytotherapy; 2018 Apr; 20(4):499-506. PubMed ID: 29428486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
